Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Biochem Pharmacol ; 46(4): 773-5, 1993 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-8363652

RESUMEN

The 1,4-dihydropyridine (1,4-DHP) and 1,4-dihydroindeno[1,2-b]pyridine (1,4-DHIP) derivatives were investigated as glutathione S-transferase (GT) inhibitors. The obtained results indicate that some of the 1,4-DHP's containing lipophylic and bulky substituents have inhibitory effects on GT in vitro. The derivatives of 1,4-DHIP are more pronounced inhibitors.


Asunto(s)
Dihidropiridinas/farmacología , Glutatión Transferasa/antagonistas & inhibidores , Piridinas/farmacología , Animales , Bovinos , Hígado/enzimología
2.
Eur J Med Chem ; 35(4): 429-38, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10858603

RESUMEN

The selective targeting of antineoplastic drugs to tumours by incorporation in low density lipoproteins (LDL) is an attractive possibility if the drug-LDL complex remains stable in the circulation and is taken up by the tumour. In previous studies we have shown that vincristine- and N-trifluoroacetyladriamycin-14-valerate-LDL complexes were unstable in vivo. We synthesized five N-substituted lipophilic derivatives of daunorubicin and studied their incorporation into LDL. Three out of five daunorubicin derivatives incorporated successfully into LDL. In vitro these complexes were more cytotoxic towards LDL receptor positive Chinese hamster ovary cells than LDL receptor negative cells. Non-specific cytotoxicity was explained by slow dissociation of the drug-LDL complex in plasma. Our results underline the importance of careful studies of plasma stability when investigating lipoproteins and other carriers in drug targeting.


Asunto(s)
Antibióticos Antineoplásicos/sangre , Antibióticos Antineoplásicos/farmacología , Daunorrubicina/sangre , Daunorrubicina/farmacología , Lipoproteínas LDL/química , Animales , Antibióticos Antineoplásicos/química , Células CHO , Cricetinae , Daunorrubicina/química , Estabilidad de Medicamentos , Humanos , Espectroscopía de Resonancia Magnética , Receptores de LDL/genética
3.
Amino Acids ; 23(4): 367-79, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12436204

RESUMEN

Despite the multitude of evidence for the beneficial effects of taurine supplementation in a variety of disease, the underlying modifying action of taurine with respect to either molecular or biochemical mechanisms is almost totally unknown. We have assessed the development of taurine analogues, particularly where there has been substitution at the suphonate or amine group. Such substitutions allow the investigator to probe the relationship between structure and function of the taurine molecule. In addition such studies should help to ascertain taurine's point of interaction with the effector molecule. These results will prepare the way for the development of the second generation of taurine analogues.


Asunto(s)
Taurina/análogos & derivados , Taurina/metabolismo , Animales , Calcio/metabolismo , Etanol/metabolismo , Homeostasis , Humanos , Estructura Molecular , Contracción Muscular/fisiología , Neurotransmisores/química , Neurotransmisores/metabolismo , Ácido gamma-Aminobutírico/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA